GGV Capital and Valor Equity Partners led a $132m Series E round in K Health.

GGV Capital and Valor Equity Partners led a $132m Series E round in K Health, a provider of data-driven digital primary care solutions, with participation from Kaiser Permanente and LTS Investments. "The world needs a new archetype for health care, and K Health’s data, world class doctors, and team are resolute enough to deliver this. GGV backs companies with potential to serve the greatest number of people, and by solving the healthcare inequities of access and affordability, K Health is one of the most impactful consumer health companies constructing the future of care for us all," Hans Tung, GGV Capital Managing Partner.